Endothelin-1 (ET-1) can stimulate insulin-responsive glucose transporter (GLUT4) translocation in 3T3-L1 adipocytes (Wu-Wong, J. R., Berg, C. E,, Wang, J,, Chiou, W, J,, and Fissel, B. (1999) J. Biol. Chem. 274, 8103-8110), and in the current study, we have evaluated the signaling pathway leading to this response. First, we inhibited endogenous Ga-q/11 function by single-cell microinjection using anti-G alpha(q/11) antibody or RGS2 protein (a GTPase activating protein for G alpha(q)) followed by immunostaining to quantitate GLUT4 translocation in 3T3-L1 adipocytes, ET-l-stimulated GLUT4 translocation was markedly decreased by 70 or 75% by microinjection of G alpha(q/11) antibody or RGS2 protein, respectively. Pretreatment of cells with the G alpha(i) inhibitor (pertussis toxin) or microinjection of a G beta gamma inhibitor (glutathione S-transferase-beta-adrenergic receptor kinase (GST-BARK)) did not inhibit ET-1-induced GLUT4 translocation, indicating that G alpha(q/11) mediates ET-1 signaling to GLUT4 translocation. Next, we found that ET-l-induced GLUT4 translocation was inhibited by the phosphatidylinositol (PI) 3-kinase inhibitors wortmannin or LY294002, but not by the phospholipase C inhibitor U-73122. ET-1 stimulated the PI 3-kinase activity of the p110 alpha subunit (5.5-fold), and microinjection of anti-p110 alpha or PKC-lambda antibodies inhibited ET-stimulated GLUT4 translocation, Finally, we found that G alpha(q/11) formed immunocomplexes with the type-A endothelin receptor and the 110 alpha subunit of PI 3-kinase and that ET-1 stimulation enhances tyrosine phosphorylation of G alpha(q/11). These results indicate that: 1) ET-1 signaling to GLUT4 translocation is dependent upon G alpha(q/11) and PI 3-kinase; and 2) G alpha(q/11) can transmit signals from the ET, receptor to the p110 alpha subunit of PI 3-kinase, as does insulin, subsequently leading to GLUT4 translocation.